Remove tag history
article thumbnail

Grand Rounds September 22, 2023: Integrating Community Health Workers into Team-Based, Early Childhood Preventative Care (Tumaini Rucker Coker, MD, MBA)

Rethinking Clinical Trials

The American Academy of Pediatrics (AAP) Bright Futures guidelines for preventive visits include history, measurements, physical exam, developmental and behavioral screening, anticipatory guidance, and psychosocial and social needs screening and guidance. How might we better structure preventive visits?

Trials 269
article thumbnail

Grand Rounds July 22, 2022: ACTIV-6: 1-Year Later and Trial Results for Ivermectin-400 and Inhaled Fluticasone (Susanna Naggie, MD, MHS)

Rethinking Clinical Trials

Given the history with other repurposed drugs, I was concerned people would not want to take Ivermectin. There was some evidence of increased acute care needs (urgent care, emergency room visit) in the fluticasone furoate arm. No safety concerns were identified. Discussion Themes. Learn more about ACTIV-6. pctGR, @Collaboratory1.

Trials 169
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Grand Rounds December 8, 2023: A Pragmatic Randomized Trial of the Jumpstart Intervention to Promote Communication about Goals of Care for Hospitalized Patients with Serious Illness (Ruth Engelberg, PhD; Erin Kross, MD; Robert Lee, MD, MS)

Rethinking Clinical Trials

It utilized a waiver of consent; all eligible patients were randomized, and randomization was stratified by hospital and history of dementia at 3 hospitals in University of Washington system. Jumpstart is a pragmatic randomized trial of Jumpstart compared to usual care. It is something we are thinking about a lot in the outpatient trial.

Trials 130
article thumbnail

The FDA and Aduhelm: WTF?

World of DTC Marketing

Not to mention the $56,000 annual price tag. Source: Fierce Pharma If that enthusiasm pans out in the long run, it could mean at least 300,000 patients taking the drug, or $10 billion to $15 billion in peak Aduhelm from U.S. sales alone, which is above consensus estimates of around $7 billion to $8 billion, the team said.

Drugs 218
article thumbnail

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

Almost 40 years since it was instituted, some have described the FDA’s orphan drug program, which is meant to foster innovation, as “ one of the most successful US legislative actions in recent history ”. Others judge its success based on the fact that 95% of rare diseases still have no available therapies and patient needs remain unmet.

Drugs 246
article thumbnail

How COVID-19 Changed Food Sampling in Retail and At Home

XTalks

Pre-pandemic, Daniel Maloney could be found working sample booths at food markets around New York City, telling consumers about the brand’s rich history and commitment to ethical farming. But without food sampling, consumers may not be able to justify the $6 price tag, let alone be aware of the brand. .

article thumbnail

A history of Pfizer

pharmaphorum

Here we take a look at the colourful history of one of the biggest drugmakers in the world. By the 1960s, Pfizer were at their “most diversified point in [its] history” – in its own words, its interests “stretched from pills to perfume, and petrochemicals to pet products”. The post A history of Pfizer appeared first on.

Sales 127